Nakazawa Fumie, Kannemeier Christian, Shibamiya Aya, Song Yutong, Tzima Eleni, Schubert Uwe, Koyama Takatoshi, Niepmann Michael, Trusheim Heidi, Engelmann Bernd, Preissner Klaus T
Graduate School of Allied Health Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8519, Japan.
Biochem J. 2005 Feb 1;385(Pt 3):831-8. doi: 10.1042/BJ20041021.
FSAP (Factor VII-activating protease) is a new plasma-derived serine protease with putative dual functions in haemostasis, including activation of coagulation Factor VII and generation of urinary-type plasminogen activator (urokinase). The (auto-)activation of FSAP is facilitated by polyanionic glycosaminoglycans, such as heparin or dextran sulphate, whereas calcium ions stabilize the active form of FSAP. In the present study, extracellular RNA was identified and characterized as a novel FSAP cofactor. The conditioned medium derived from various cell types such as smooth muscle cells, endothelial cells, osteosarcoma cells or CHO (Chinese-hamster ovary) cells contained an acidic factor that initiated (auto-)activation of FSAP. RNase A, but not other hydrolytic enzymes (proteases, glycanases and DNase), abolished the FSAP cofactor activity, which was subsequently isolated by anion-exchange chromatography and unequivocally identified as RNA. In purified systems, as well as in plasma, different forms of natural RNA (rRNA, tRNA, viral RNA and artificial RNA) were able to (auto-)activate FSAP into the two-chain enzyme form. The specific binding of FSAP to RNA (but not to DNA) was shown by mobility-shift assays and UV crosslinking, thereby identifying FSAP as a new extracellular RNA-binding protein, the K(D) estimated to be 170-350 nM. Activation of FSAP occurred through an RNA-dependent template mechanism involving a nucleic acid size of at least 100 nt. In a purified system, natural RNA augmented the FSAP-dependent Factor VII activation several-fold (as shown by subsequent Factor Xa generation), as well as the FSAP-mediated generation of urokinase. Our results provide evidence for the first time that extracellular RNA, present at sites of cell damage or vascular injury, can serve an important as yet unrecognized cofactor function in haemostasis by inducing (auto-)activation of FSAP through a novel surface-dependent mechanism.
FSAP(因子VII激活蛋白酶)是一种新的血浆来源的丝氨酸蛋白酶,在止血过程中具有假定的双重功能,包括激活凝血因子VII和生成尿激酶型纤溶酶原激活剂(尿激酶)。多阴离子糖胺聚糖(如肝素或硫酸葡聚糖)可促进FSAP的(自)激活,而钙离子则稳定FSAP的活性形式。在本研究中,细胞外RNA被鉴定并表征为一种新型的FSAP辅因子。来自各种细胞类型(如平滑肌细胞、内皮细胞、骨肉瘤细胞或CHO(中国仓鼠卵巢)细胞)的条件培养基中含有一种酸性因子,该因子可启动FSAP的(自)激活。核糖核酸酶A而非其他水解酶(蛋白酶、聚糖酶和脱氧核糖核酸酶)可消除FSAP辅因子活性,随后通过阴离子交换色谱法分离该辅因子,并明确鉴定为RNA。在纯化系统以及血浆中,不同形式的天然RNA(核糖体RNA、转运RNA、病毒RNA和人工RNA)能够将FSAP(自)激活为双链酶形式。迁移率变动分析和紫外线交联显示FSAP与RNA(而非DNA)有特异性结合,从而将FSAP鉴定为一种新的细胞外RNA结合蛋白,其解离常数估计为170 - 350 nM。FSAP的激活通过一种依赖RNA的模板机制发生,涉及至少100 nt的核酸大小。在纯化系统中,天然RNA使FSAP依赖的因子VII激活增加了几倍(如随后生成的因子Xa所示),以及FSAP介导的尿激酶生成。我们的结果首次证明,存在于细胞损伤或血管损伤部位的细胞外RNA可通过一种新的表面依赖机制诱导FSAP的(自)激活,从而在止血过程中发挥重要但尚未被认识的辅因子功能。